Skip to main content

Table 1 Seven previous reports and 2 episodes of neurotoxicity and nephrotoxicity in our patient caused by combined use of lithium and risperidone

From: Neurotoxicity and nephrotoxicity caused by combined use of lithium and risperidone: a case report and literature review

R.N.

Age

Sex

Diagnosis

Risperidone dose (mg)

Lithium dose (mg)

Time to onseta

Clinical presentation

Laboratory values and Image

[3]

69

F

BD

6

450

3 weeks

Delirium

Cr: NA; Li: 1.36

[4]

30

M

BD

NA

900

1 week

NMS

Cr: 1.6; Li: 0.6; CPK: 1428

[5]

46

M

NA

3

900

2 years

NMS, DKA

BUN: 66

[6]

54

F

BD

3

1500

2 months

NMS

Cr: NA; Li: 0.7; CPK: 791

[7]

60

F

SD

6

NA

3 weeks

Delirium

EEG: Abnormal; CK: 953

[8]

75

M

BD

2

900

4 days

Lethargy

EEG: Abnormal; Cr: NA; Li: 1.47

[9]

60

F

SD

6

NA

6 days

NMS

EEG: Abnormal; CPK: 953

Ib

56

M

SD

4.5c

900

12 days

Delirium

BUN/Cr: 24/1.33; Li: 1.42; CK: 975

IIb

3

600

3 days

Delirium

BUN/Cr: 29/1.36; Li: 1.54; CK: 90

  1. aTime is calculated from beginning the combination of lithium and risperidone to the occurrence of adverse events
  2. bI and II are serial numbers of the 2 episodes of our patient during hospitalization
  3. cIM Risperidone 25 mg/vial was prescribed 7 days before oral risperidone